Could an antiviral lift depression? small trial explores link
NCT ID NCT04724447
First seen May 08, 2026 · Last updated May 08, 2026
Summary
This study tested whether an antiviral drug (valganciclovir) could help treat depression in people who also carry the common cytomegalovirus (CMV). Twenty adults with major depression took either the drug or a placebo for 8 weeks. Researchers checked for changes in brain scans, inflammation, and mood symptoms. The goal was to see if treating the virus could improve depression.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Laureate Institute for Brain Research
Tulsa, Oklahoma, 74136, United States
Conditions
Explore the condition pages connected to this study.